pharma · Chikungunya Virus
Bavarian Nordic
Bavarian Nordic A/S
Bavarian Nordic A/S is a pharma organization headquartered in HELLERUP, DK. Primary therapeutic focus areas include Chikungunya Virus. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s)
Copenhagen, DK HQ
1994 Founded
1,730 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Copenhagen, DK
- Founded
- 1994
- Employees
- 1,730
- Programs
- 1
- Drugs
- 1
- Patents
- 25
CHIKV VLP vaccine
Phase 3 · mab · Chikungunya Virus
CHIKV VLP vaccine for Chikungunya Virus is a Phase 3 program (mab) at Bavarian Nordic A/S with 2 ClinicalTrials.gov record(s).
Internal code EBSI-CV-317-007
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Bavarian Nordic A/S
- Phase
- Phase 3
- Modality
- mab
- Indication
- Chikungunya Virus
- Status
- active
- Trials
- 2